I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Chamoun, Kamal
81
results:
Search for persons
X
Format
Online (81)
Mediatypes
Articles (Online) (26)
OpenAccess-fulltext (55)
Sorted by: Relevance
Sorted by: Year
?
1
POSTER: MPN-336 Selinexor Plus Ruxolitinib in JAK Inhibitor..:
Ali, Haris
;
Kishtagari, Ashwin
;
Maher, Keri
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S195 , 2023
Link:
https://doi.org/10.1016/..
?
2
P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBI..:
Ali, Haris
;
Kishtagari, Ashwin
;
Maher, Keri
...
HemaSphere. 7 (2023) S3 - p. e402391a , 2023
Link:
https://doi.org/10.1097/..
?
3
MPN-336 Selinexor Plus Ruxolitinib in JAK Inhibitor (JAKi) ..:
Ali, Haris
;
Kishtagari, Ashwin
;
Maher, Keri
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S389 , 2023
Link:
https://doi.org/10.1016/..
?
4
Effect of Prior Therapy and Disease Refractoriness on the E..:
Schuster, Michael
;
Zijlstra, Josée
;
Casasnovas, Rene-Olivier
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 7 - p. 483-494 , 2022
Link:
https://doi.org/10.1016/..
?
5
The Association between Patient Characteristics and the Eff..:
Zijlstra, Josée M.
;
Follows, George
;
Casasnovas, Rene-Olivier
...
Cancers. 14 (2022) 3 - p. 791 , 2022
Link:
https://doi.org/10.3390/..
?
6
Oral eltanexor treatment of patients with higher-risk myelo..:
Lee, Sangmin
;
Mohan, Sanjay
;
Knupp, Jessica
...
Journal of Hematology & Oncology. 15 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
7
Comparison of the Effectiveness and Safety of the Oral Sele..:
Casasnovas, Rene-Olivier
;
Follows, George
;
Zijlstra, Josee M.
...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 1 - p. 24-33 , 2022
Link:
https://doi.org/10.1016/..
?
8
Socioeconomic Factors and Survival of Multiple Myeloma Pati..:
Chamoun, Kamal
;
Firoozmand, Amin
;
Caimi, Paolo
...
Cancers. 13 (2021) 4 - p. 590 , 2021
Link:
https://doi.org/10.3390/..
?
9
Survival among patients with relapsed/refractory diffuse la..:
Maerevoet, Marie
;
Zijlstra, Josee M.
;
Follows, George
...
Journal of Hematology & Oncology. 14 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
10
A case of neurocognitive deficit strongly related to dasati..:
Chamoun, Kamal
;
Rabinovich, Emma
;
Baer, Linda
..
Hematology, Transfusion and Cell Therapy. 42 (2020) 1 - p. 80-82 , 2020
Link:
https://doi.org/10.1016/..
?
11
Unrecognized fluid overload during induction therapy increa..:
Chamoun, Kamal
;
Kantarjian, Hagop M.
;
Wang, Xuemei
...
Cancer. 125 (2019) 18 - p. 3219-3224 , 2019
Link:
https://doi.org/10.1002/..
?
12
Impact of Regional Income and Insurance Status on Survival ..:
Chamoun, Kamal
;
De Lima, Marcos
;
Fu, Pingfu
...
Clinical Lymphoma Myeloma and Leukemia. 19 (2019) 10 - p. e211-e212 , 2019
Link:
https://doi.org/10.1016/..
?
13
Peri-Transplant Venous Thromboembolism in Patients with Mul..:
Chamoun, Kamal
;
Covut, Fahrettin
;
Park, Michelle
...
Biology of Blood and Marrow Transplantation. 25 (2019) 3 - p. S404-S405 , 2019
Link:
https://doi.org/10.1016/..
?
14
Tyrosine kinase inhibitor discontinuation in patients with ..:
Chamoun, Kamal
;
Kantarjian, Hagop
;
Atallah, Rami
...
Journal of Hematology & Oncology. 12 (2019) 1 - p. , 2019
Link:
https://doi.org/10.1186/..
?
15
Oral Vs Intravenous Tacrolimus Post Allogeneic Stem Cell Tr..:
Chamoun, Kamal
;
Getz, Theodore
;
Kolk, Merle
...
Biology of Blood and Marrow Transplantation. 25 (2019) 3 - p. S117-S118 , 2019
Link:
https://doi.org/10.1016/..
1-15